Provided by Tiger Trade Technology Pte. Ltd.

Integra Lifesciences

11.53
-0.2300-1.96%
Post-market: 11.530.00000.00%16:20 EST
Volume:525.87K
Turnover:6.10M
Market Cap:898.10M
PE:-1.78
High:11.89
Open:11.74
Low:11.51
Close:11.76
52wk High:25.45
52wk Low:10.60
Shares:77.89M
Float Shares:59.27M
Volume Ratio:0.73
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4719
EPS(LYR):-0.0902
ROE:-38.71%
ROA:2.61%
PB:0.87
PE(LYR):-127.87

Loading ...

Director Makes Bold Move with Major Stock Purchase in Integra Lifesciences

TIPRANKS
·
Nov 07, 2025

Director Jeffrey A. Graves Acquires Common Shares of Integra LifeSciences Holdings Corporation

Reuters
·
Nov 07, 2025

Integra LifeSciences Price Target Cut to $13.00/Share From $15.00 by Truist Securities

Dow Jones
·
Nov 03, 2025

Stock Track | Integra Lifesciences Plummets 5% as Truist Securities Slashes Price Target

Stock Track
·
Nov 03, 2025

Stock Track | Integra Lifesciences Plummets 5.08% as Truist Securities Slashes Price Target

Stock Track
·
Nov 03, 2025

Integra LifeSciences price target lowered to $13 from $15 at Truist

TIPRANKS
·
Nov 03, 2025

Integra LifeSciences Is Maintained at Sell by Citigroup

Dow Jones
·
Nov 01, 2025

Integra Lifesciences (IART) Receives a Sell from Morgan Stanley

TIPRANKS
·
Oct 31, 2025

Integra LifeSciences price target raised to $13 from $12 at JPMorgan

TIPRANKS
·
Oct 31, 2025

Integra Lifesciences Faces Revenue Shortfall and Lowered Outlook Amid Supply Chain Challenges

TIPRANKS
·
Oct 31, 2025

Integra LifeSciences (IART): Deep Valuation Discount Tests Profitability Timeline, Spotlights Risk-Reward Divide

Simply Wall St.
·
Oct 31, 2025

Integra LifeSciences Declines on FY Outlook Cut After Supply Chain Issues

Dow Jones
·
Oct 31, 2025

Stock Track | Integra Lifesciences Plummets 6.03% as Q3 Revenue Misses Estimates and Guidance Disappoints

Stock Track
·
Oct 30, 2025

Stock Track | Integra LifeSciences Plummets 6.03% on Q3 Revenue Miss and Lowered Guidance

Stock Track
·
Oct 30, 2025

Surgical devices maker Integra misses Q3 revenue estimates, adjusts FY forecast

Reuters
·
Oct 30, 2025

Integra Lifesciences Q3 Adj. EPS $0.54 Beats $0.43 Estimate, Sales $402.062M Miss $414.256M Estimate

Benzinga
·
Oct 30, 2025

BRIEF-Integra Lifesciences Q3 Adjusted EPS USD 0.54 Vs. IBES Estimate USD 0.43

Reuters
·
Oct 30, 2025

Integra Lifesciences Holdings Corp - Expects Q4 Adj EPS Between $0.79 and $0.84

THOMSON REUTERS
·
Oct 30, 2025

Integra Lifesciences Outlook FY Adjusted EPS USD 2.19-2.24

THOMSON REUTERS
·
Oct 30, 2025

Integra Lifesciences Holdings Corp - Expects Q4 Revenues Between $420 Mln and $440 Mln

THOMSON REUTERS
·
Oct 30, 2025